Page 2 - Stock Market Listing

Corona Remedies makes bumper D-St debut; lists at 38% premium on bourses

Corona Remedies shares opened at ₹1,470 on the NSE, a premium of ₹408 or 38 per cent from the issue price of ₹1,062

Corona Remedies IPO to list on Dec 15; here's what GMP hints for D-St debut

Corona Remedies IPO received an overwhelming investor interest, achieving an overall oversubscription of 137 times, driven largely by strong participation from QIBs

Aequs lists at 13% premium; analysts flag upside with caution; find out why

Analysts suggest investors to hold for long term, citing the company's strong positioning as one of India's most advanced aerospace precision-manufacturing platforms

Meesho lists at 46% premium; analysts upbeat on long-term view; here's why

Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability

Vidya Wires makes flat D-street debut at ₹52; misses GMP estimates

Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price

Aequs IPO listing on December 10: Here's what latest GMP indicates

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent

Meesho IPO to make D-St debut on Dec 10: Here's what latest GMP hints at

Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer

Meesho IPO subscribed 2.4 times on day one; retail book nearly four times

Meesho's IPO was subscribed 2.4 times on the first day, driven by strong retail demand, after it raised Rs 2,440 crore from anchors and set a price band of Rs 105-111 per share

Sudeep Pharma makes positive D-St debut; lists at 23% premium on bourses

Sudeep Pharma shares opened at ₹733.95, a premium of ₹140.95 or 23.8 per cent

Sudeep Pharma IPO to list on Nov 28: Here's what latest GMP hints at

Sudeep Pharma IPO witnessed robust investor interest, getting oversubscribed 93.72 times overall, driven largely by strong participation from QIBs

Excelsoft Tech makes positive D-St debut; lists at 12% premium on bourses

Excelsoft Technologies shares listed at ₹135 per share on the NSE, opening with a 12.5 per cent premium over the issue price of ₹120

Excelsoft Tech IPO to list on Nov 26; here's what GMP hints for D-St debut

Excelsoft's unlisted shares were trading at around ₹125.5 per share in the grey market, indicating a premium of ₹5.5 or 4.6 per cent

Tenneco Clean Air stock lists at 27% premium; should you buy, sell or hold?

Tenneco Clean Air stock listed at ₹505 on the NSE, opening with a 27 per cent premium over the issue price of ₹397 per share

PhysicsWallah makes solid debut; analysts split on outlook; hold or sell?

PhysicsWallah stock made a solid debut on Dalal Street, listing at ₹145 on the NSE, a 33 per cent premium compared to the issue price of ₹109

Bumper debut! PhysicsWallah lists at 33% premium, beats GMP forecasts

PhysicsWallah share price: On the BSE, the PhysicsWallah shares opened at ₹143.1, a premium of 31.2 per cent

Lenskart lists flat after volatile debut; valuation debate lingers

Eyewear retailer Lenskart's stock fluctuated sharply on listing day, ending nearly unchanged as investors weighed its steep valuation and long-term growth potential

Cognizant looking to list on Indian exchanges, says IT firm's senior exec

Cognizant CFO Jatin Dalal said the company is evaluating a primary offering and secondary listing in India, potentially becoming the first foreign IT major to list on Indian bourses

Eyewear retailer Lenskart promoters set to cash in on $830 million IPO

SoftBank-backed eyewear giant aims for $8 billion valuation as co-founders and early investors book multibillion-rupee gains

Five firms, including Milky Mist and Curefoods, get Sebi IPO approval

As many as five firms, including dairy products maker Milky Mist Dairy Food, cloud kitchens operator Curefoods India, have secured Sebi's approval to raise funds through initial public offerings (IPO), an update with the markets regulator showed on Monday. Others that received regulatory approval are industrial steam and gas supplier Steamhouse India, Gaja Alternative Asset Management Ltd, which operates under the brand Gaja Capital, and cement manufacturing company Kanodia Cement. All five companies, which filed their preliminary IPO papers with Sebi between May and July, obtained its observations during October 14 to 24, the update showed. In regulatory terms, Sebi's observation is equivalent to clearance for launching a public issue. The approval comes at a time when the Indian market is experiencing a boom in primary market activity. In 2025, a total of 84 companies have already tapped the mainboard market through maiden public offerings, and two issues, including eyewear retai

IPO frenzy ahead as over a dozen firms plan to raise ₹2.6 trillion

The primary market remains buoyant, with more than a dozen companies gearing up to launch their initial public offerings (IPOs) in the coming months, aiming to raise about Rs 2.6 lakh crore (nearly USD 28 billion), Chirag Setalvad, Fund Manager at HDFC Mutual Fund, said on Friday. Of this, Tata Capital, LG Electronics India, and WeWork India Management have already raised around Rs 30,000 crore collectively. The upcoming line-up includes prominent names such as PhonePe, ICICI Prudential AMC, Lenskart, Groww, Inox Clean Energy, Pine Labs, Credila, Clean Max Enviro, Dorf Ketal Chemicals, Fractal Analytics, Meesho, SMPP, and Yashoda Hospitals, he said in a webinar. So far this year, 81 companies have debuted on the stock exchanges, with nearly three dozen listings taking place in September and October alone, highlighting the depth of activity in the primary market. The robust activity comes on the back of a solid 2024, when 91 public issues collectively mobilised Rs 1.6 lakh crore, ..